Acadian Asset Management LLC Relmada Therapeutics, Inc. Transaction History
Acadian Asset Management LLC
- $34.5 Billion
- Q4 2024
A detailed history of Acadian Asset Management LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,227,928 shares of RLMD stock, worth $356,099. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,227,928
Previous 1,186,452
3.5%
Holding current value
$356,099
Previous $3.84 Million
83.45%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding RLMD
# of Institutions
54Shares Held
8.29MCall Options Held
364KPut Options Held
46.5K-
Franklin Resources Inc San Mateo, CA1.3MShares$377,6230.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$364,4440.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$166,2610.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$143,5920.04% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$87,8230.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $8.3M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...